Background Closed-loop artificial pancreas systems have been in development for several
years, including assessment in numerous varied outpatient clinical trials. We aimed to …

Objective To evaluate the efficacy and safety of artificial pancreas treatment in non-pregnant
outpatients with type 1 diabetes. Design Systematic review and meta-analysis of …

Introduction Several different forms of automated insulin delivery systems (AID systems)
have recently been developed and are now licensed for type 1 diabetes (T1D). We …

Background The feasibility, safety, and efficacy of prolonged use of an artificial beta cell
(closed-loop insulin-delivery system) in the home setting have not been established …

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies Page 1 ISPAD
CLINICAL PRACTICE CONSENSUS GUIDELINES ISPAD Clinical Practice Consensus …

Abstract Since Banting and Best isolated insulin in the 1920s, dramatic progress has been
made in the treatment of type 1 diabetes mellitus (T1DM). However, dose titration and timely …

This paper presents a methodological review of models for predicting blood glucose (BG)
concentration, risks and BG events. The surveyed models are classified into three …

Background In patients with type 1 diabetes who are not pregnant, closed-loop (automated)
insulin delivery can provide better glycemic control than sensor-augmented pump therapy …

Background: Closed-loop artificial pancreas device (APD) systems are externally worn
medical devices that are being developed to enable people with type 1 diabetes to regulate …

Background An artificial pancreas (AP) that can be worn at home from dinner to waking up in
the morning might be safe and efficient for first routine use in patients with type 1 diabetes …